Members from Danaher Diagnostics provided clinical commentary and insights on an emerging immunoassay geared towards testing apolipoprotein (APOE) in patients with suspected Alzheimer disease.
Scott Levin, PhD
Advertisement
Vice President, Clinical Science & Evidence Generation, Danaher Diagnostics
Articles by Scott Levin, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Expanding Role of Blood-Based Biomarkers in Alzheimer Disease
2
Beyond AAV: How Extracellular Vesicles Are Opening a New Chapter in Duchenne Gene Therapy
3
Advances in Fragile X Syndrome Therapeutics: Overviewing the Pipeline
4
The Role of Cerebrospinal Fluid in Personalized Alzheimer Disease Care: Betty Tijms, PhD
5